114 related articles for article (PubMed ID: 19139781)
1. Anti-inflammatory activity of silymarin in patients with knee osteoarthritis. A comparative study with piroxicam and meloxicam.
Hussain SA; Jassim NA; Numan IT; Al-Khalifa II; Abdullah TA
Saudi Med J; 2009 Jan; 30(1):98-103. PubMed ID: 19139781
[TBL] [Abstract][Full Text] [Related]
2. Endoscopic comparison of the gastroduodenal safety and the effects on arachidonic acid products between meloxicam and piroxicam in the treatment of osteoarthritis.
Chang DM; Young TH; Hsu CT; Kuo SY; Hsieh TC
Clin Rheumatol; 2001; 20(2):104-13. PubMed ID: 11346221
[TBL] [Abstract][Full Text] [Related]
3. Modelling therapeutic strategies in the treatment of osteoarthritis: an economic evaluation of meloxicam versus diclofenac and piroxicam.
Tavakoli M
Pharmacoeconomics; 2003; 21(6):443-54. PubMed ID: 12678570
[TBL] [Abstract][Full Text] [Related]
4. Improvement in gastrointestinal tolerability of the selective cyclooxygenase (COX)-2 inhibitor, meloxicam, compared with piroxicam: results of the Safety and Efficacy Large-scale Evaluation of COX-inhibiting Therapies (SELECT) trial in osteoarthritis.
Dequeker J; Hawkey C; Kahan A; Steinbrück K; Alegre C; Baumelou E; Bégaud B; Isomäki H; Littlejohn G; Mau J; Papazoglou S
Br J Rheumatol; 1998 Sep; 37(9):946-51. PubMed ID: 9783758
[TBL] [Abstract][Full Text] [Related]
5. Comparison of endoscopic gastric mucosa features after administration of piroxicam to meloxicam and their correlation with dyspepsia symptoms in elderly patient with knee osteoarthritis.
Girawan D; Abdurachman SA; Djumhana A; Roslia J; Pramudiyo R
Acta Med Indones; 2004; 36(4):202-6. PubMed ID: 15673949
[TBL] [Abstract][Full Text] [Related]
6. Meloxicam in acute episodes of soft-tissue rheumatism of the shoulder.
Vidal L; Kneer W; Baturone M; Sigmund R
Inflamm Res; 2001 Mar; 50 Suppl 1():S24-9. PubMed ID: 11339517
[TBL] [Abstract][Full Text] [Related]
7. Tolerability of multiple administration of intramuscular meloxicam: a comparison with intramuscular piroxicam in patients with rheumatoid arthritis or osteoarthritis.
Ghozlan PR; Bernhardt M; Vélicitat P; Bluhmki E
Br J Rheumatol; 1996 Apr; 35 Suppl 1():51-5. PubMed ID: 8630638
[TBL] [Abstract][Full Text] [Related]
8. A comparison of the local tolerability, safety and efficacy of meloxicam and piroxicam suppositories in patients with osteoarthritis: a single-blind, randomized, multicentre study.
Carrabba M; Paresce E; Angelini M; Galanti A; Marini MG; Cigarini P
Curr Med Res Opin; 1995; 13(6):343-55. PubMed ID: 8829892
[TBL] [Abstract][Full Text] [Related]
9. Meloxicam.
Noble S; Balfour JA
Drugs; 1996 Mar; 51(3):424-30; discussion 431-32. PubMed ID: 8882380
[TBL] [Abstract][Full Text] [Related]
10. A double-blind study to compare the efficacy and safety of meloxicam 15 mg with piroxicam 20 mg in patients with osteoarthritis of the hip.
Lindén B; Distel M; Bluhmki E
Br J Rheumatol; 1996 Apr; 35 Suppl 1():35-8. PubMed ID: 8630634
[TBL] [Abstract][Full Text] [Related]
11. Double blind crossover trial of piroxicam and naproxen in the treatment of osteoarthritis of hip and knee.
Kogstad O
Br J Clin Pract; 1981 Jan; 35(1):45-50. PubMed ID: 7020733
[No Abstract] [Full Text] [Related]
12. Ankylosing spondylitis: what is the optimum duration of a clinical study? A one year versus a 6 weeks non-steroidal anti-inflammatory drug trial.
Dougados M; Gueguen A; Nakache JP; Velicitat P; Veys EM; Zeidler H; Calin A
Rheumatology (Oxford); 1999 Mar; 38(3):235-44. PubMed ID: 10325662
[TBL] [Abstract][Full Text] [Related]
13. Comparison of meloxicam and a glucosamine-chondroitin supplement in management of feline osteoarthritis. A double-blind randomised, placebo-controlled, prospective trial.
Sul RM; Chase D; Parkin T; Bennett D
Vet Comp Orthop Traumatol; 2014; 27(1):20-6. PubMed ID: 24146058
[TBL] [Abstract][Full Text] [Related]
14. [Acemetacin in the treatment of arthroses of the hip and knee joints. Results of a double blind trial compared with piroxicam].
Kronhagel R
Fortschr Med; 1985 Feb; 103(5):99-103. PubMed ID: 3882537
[No Abstract] [Full Text] [Related]
15. A comparison of the efficacy and tolerability of meloxicam and diclofenac in the treatment of patients with osteoarthritis of the lumbar spine.
Valat JP; Accardo S; Reginster JY; Wouters M; Hettich M; Lieu PL;
Inflamm Res; 2001 Mar; 50 Suppl 1():S30-4. PubMed ID: 11339519
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the safety, tolerability, and efficacy of meloxicam tablets in patients with osteoarthritis.
Prouse PJ; Bevis PJ; Bluhmki E; Distel M
Clin Ther; 1996; 18(3):429-39. PubMed ID: 8829018
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of piroxicam and indomethacin retard in osteoarthritis.
Muller-Fassbender HH; Nagel E
Eur J Rheumatol Inflamm; 1983; 6(1):106-12. PubMed ID: 6861809
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of combination of meloxicam and pregabalin for pain in knee osteoarthritis.
Ohtori S; Inoue G; Orita S; Takaso M; Eguchi Y; Ochiai N; Kishida S; Kuniyoshi K; Aoki Y; Ishikawa T; Miyagi M; Kamoda H; Suzkuki M; Nakamura J; Kubota G; Sakuma Y; Oikawa Y; Toyone T; Inage K; Sainoh T; Yamauchi K; Takahashi K
Yonsei Med J; 2013 Sep; 54(5):1253-8. PubMed ID: 23918578
[TBL] [Abstract][Full Text] [Related]
19. Piroxicam and naproxen in the treatment of osteoarthritis.
Hybbinette CH
Br J Clin Pract; 1981 Jan; 35(1):30-4. PubMed ID: 7020730
[No Abstract] [Full Text] [Related]
20. Anti-tumor effect of non-steroidal anti-inflammatory drugs on human ovarian cancers.
Xin B; Yokoyama Y; Shigeto T; Mizunuma H
Pathol Oncol Res; 2007; 13(4):365-9. PubMed ID: 18158574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
